Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Immunotherapy after surgery may keep colon cancer from returning

NCT ID NCT07140679

First seen Oct 31, 2025 · Last updated May 01, 2026 · Updated 24 times

Summary

This study tests whether the immunotherapy drug toripalimab can lower the chance of cancer coming back after surgery in people with a specific type of high-risk colon cancer (mismatch repair deficient). About 40 adults with stage IIB, IIC, or III colon cancer will receive toripalimab for up to a year. The main goal is to see how many remain cancer-free after three years.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LOCALIZED COLON CARCINOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Emory Decatur Hospital

    RECRUITING

    Atlanta, Georgia, 30033, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Emory Johns Creek Hospital

    RECRUITING

    Johns Creek, Georgia, 30097, United States

    Contact Email: •••••@•••••

    Contact

  • Emory Saint Joseph's Hospital

    RECRUITING

    Atlanta, Georgia, 30342, United States

    Contact Email: •••••@•••••

    Contact

  • Emory University Hospital Midtown

    RECRUITING

    Atlanta, Georgia, 30308, United States

    Contact Email: •••••@•••••

    Contact

  • Emory University Hospital/Winship Cancer Institute

    RECRUITING

    Atlanta, Georgia, 30322, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.